Tim Vanmierlo (T.)
Dr. Tim Vanmierlo is heading the Division Translational Neuroscience within MHeNs.
The mission of the division Translational Neuroscience is to improve significantly the understanding of the mechanisms mediating normal and aberrant functioning of the nervous system, and to innovate clinical care at the levels of prevention, diagnosis and treatment for patients with disorders of the nervous system.
Dr. Vanmierlo's personal research interests span a wide spectrum of topics in translational neuroscience, including neurodegeneration, central nervous system (CNS) repair, and more. His primary focus revolves around the development of cognitive enhancers that promote repair in the context of neurodegenerative diseases, with a special emphasis on Alzheimer's disease and multiple sclerosis. Dr. Vanmierlo also maintains a strong interest in elucidating the mechanisms of diseases associated with glia biology and exploring innovative treatment approaches aimed at fostering CNS repair.
He currently holds a joint position between Maastricht University and the University of Hasselt (BIOMED), both of which are integral partners in our EURON network.
In his team, he currently supervises 3 postdocs and 13 PhD students as promotor, and 2 PhD students as co-promotor.
You can contact us for:
- Questions related to the division Translational Neuroscience.
- Functional and molecular readouts in animal models of multiple sclerosis and Alzheimer’s disease
- Molecular and cellular setups in relation to oligodendrocyte differentiation
- In vitro and in vivo gene-editing tools to modulate (epi)genetic processes on the cellular level (e.g. CRISPR/Cas9, in vivo micro-electroporation)
Tim Vanmierlo (T.)
Tim Vanmierlo holds a position as an associate professor between Maastricht University (0.5fte) and Hasselt University (0.5fte) and on the research line "repair-inducing cognition enhancers". In this context, his team applies a battery of gene-editing approaches (e.g. CRISPR/Cas9, in vivo micro-electroporation) to modulate biological processes to enable CNS repair in MS and AD. The established cross-border initiative between UHasselt BIOMED with the school for mental health and neuroscience (MHeNs) at Maastricht University merges knowledge and expertise on cognition enhancers applying gene-editing approaches.